 |
|
|
| |
Patient-reported outcomes (PROs) after 1 year of routine clinical practice with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF): The BICSTaR cohort
|
| |
| |
Glasgow 2020 Oct 5-8 virtual
Reported by Jules Levin
H Knechten1, C Stephan2, M Waizmann3, J Brunetta4, B Trottier5, F Bonnet6, C Duvivier7, B van Welzen8, F Mack9, H Tossonian10, D Thorpe11, A Torres Cornejo12, A Marongiu11, R Curbelo13
|
| |
|
|
|
|
|
